Topiramate oral solution is indicated for: Epilepsy: Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older; adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox- Gastaut syndrome in patients 2 years of age and older., Preventive treatment of migraine in patients 12 years of age and older.
From the U.S. FDA-approved label for Topiramate. Full label: DailyMed.
Topiramate oral solution is indicated for: Epilepsy: Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older; adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox- Gastaut syndrome in patients 2 years of age and older., Preventive treatment of migraine in patients 12 years of age and older. 1.3 Migraine Topiramate oral solution is indicated for the preventive treatment of migraine in patients 12 years of age and older.
From the U.S. FDA-approved label for Topiramate. Full label: DailyMed.
Topiramate oral solution initial dose, titration, and recommended maintenance dose varies by indication and age group. See Full Prescribing Information for recommended dosage, and dosing considerations in patients with renal impairment, geriatric patients, and patients undergoing hemodialysis. 2.1 Dosing in Monotherapy Epilepsy Adults and Pediatric Patients 10 Years of Age and Older The recommended dose for topiramate oral solution monotherapy in adults and pediatric patients 10 years of age and older is 400 mg/day in two divided doses.
Directions from the U.S. FDA-approved label for Topiramate — your doctor or pharmacist may advise differently.
Acute myopia and secondary angle closure glaucoma: can lead to permanent visual loss; discontinue topiramate oral solution as soon as possible., Visual field defects: consider discontinuation of topiramate oral solution., Oligohidrosis and hyperthermia: monitor decreased sweating and increased body temperature, especially in pediatric patients., Metabolic acidosis: baseline and periodic measurement of serum bicarbonate is recommended; consider dose reduction or discontinuation of topiramate oral solution if clinically appropriate.…
Warnings and precautions excerpt from the U.S. FDA-approved label for Topiramate — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are discussed in more detail in other sections of the labeling: Acute Myopia and Secondary Angle Closure Glaucoma Syndrome, Visual Field Defects, Oligohidrosis and Hyperthermia, Metabolic Acidosis, Suicidal Behavior and Ideation, Cognitive/Neuropsychiatric Adverse Reactions, Decrease of Bone Mineral Density, Negative Effects on Growth (Height and Weight), Serious Skin Reactions,…
Excerpt from the U.S. FDA-approved label for Topiramate — not a complete list. Talk to a pharmacist or doctor about side effects.
11 brands · 6 makers in the NepalDoc catalog — see the full Topiramate guide →
Stored in well-closed container at controlled room temperature 20°C to 25°C (68°F to 77°F);
Storage information from the U.S. FDA-approved label for Topiramate.
What is Topamate 25?
Topamate 25mg Tablet is a Topiramate medicine made by Cipla Ltd. It comes as 25mg Tablet.
What is the generic name of Topamate 25?
The generic name of Topamate 25 is Topiramate.
Which brands of Topiramate are available in Nepal?
11 brands of Topiramate are listed in the NepalDoc catalog, from 6 makers — including Migracare 25mg Tablet, Ripot 50mg Tablet, Topamac 25mg Tablet, Topaz 100mg Tablet, Topaz 200mg Tablet, Topaz 25mg Tablet.
What are the side effects of Topiramate?
The following serious adverse reactions are discussed in more detail in other sections of the labeling: Acute Myopia and Secondary Angle Closure Glaucoma Syndrome, Visual Field Defects, Oligohidrosis and Hyperthermia, Metabolic Acidosis, Suicidal Behavior and Ideation, Cognitive/Neuropsychiatric Adverse Reactions, Decrease of Bone Mineral Density, Negative Effects on Growth (Height and Weight), Serious Skin Reactions,…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.
